[go: up one dir, main page]

AU3897200A - Endothelial cell stimulation by a complex of fibronectin and vascular endothelial growth factor - Google Patents

Endothelial cell stimulation by a complex of fibronectin and vascular endothelial growth factor

Info

Publication number
AU3897200A
AU3897200A AU38972/00A AU3897200A AU3897200A AU 3897200 A AU3897200 A AU 3897200A AU 38972/00 A AU38972/00 A AU 38972/00A AU 3897200 A AU3897200 A AU 3897200A AU 3897200 A AU3897200 A AU 3897200A
Authority
AU
Australia
Prior art keywords
fibronectin
complex
growth factor
cell stimulation
vascular endothelial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38972/00A
Inventor
William P. Hammond
Jacqueline Murray-Wijelath
Errol S. Wijelath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hope Heart Institute
Original Assignee
Hope Heart Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hope Heart Institute filed Critical Hope Heart Institute
Publication of AU3897200A publication Critical patent/AU3897200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU38972/00A 1999-03-18 2000-03-17 Endothelial cell stimulation by a complex of fibronectin and vascular endothelial growth factor Abandoned AU3897200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12500699P 1999-03-18 1999-03-18
US60125006 1999-03-18
PCT/US2000/007183 WO2000055206A1 (en) 1999-03-18 2000-03-17 Endothelial cell stimulation by a complex of fibronectin and vascular endothelial growth factor

Publications (1)

Publication Number Publication Date
AU3897200A true AU3897200A (en) 2000-10-04

Family

ID=22417805

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38972/00A Abandoned AU3897200A (en) 1999-03-18 2000-03-17 Endothelial cell stimulation by a complex of fibronectin and vascular endothelial growth factor

Country Status (2)

Country Link
AU (1) AU3897200A (en)
WO (1) WO2000055206A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7112320B1 (en) 1995-06-07 2006-09-26 Andre Beaulieu Solid wound healing formulations containing fibronectin
US6733755B2 (en) * 2000-02-04 2004-05-11 Supratek Pharma, Inc. Ligand for vascular endothelial growth factor receptor
AUPR030900A0 (en) * 2000-09-22 2000-10-12 Queensland University Of Technology Growth factor complex
US7232802B2 (en) 2001-12-21 2007-06-19 Zimmer Orthobiologics, Inc. Compositions and methods for promoting myocardial and peripheral angiogenesis
AU2003900481A0 (en) 2003-02-05 2003-02-20 Queensland University Of Technology Synthetic modulators of cell migration and growth
US8871709B2 (en) * 2003-02-05 2014-10-28 Queensland University of Technolgy Synthetic chimeric proteins comprising epidermal growth factor and vitronectin
US20100143442A1 (en) * 2003-02-05 2010-06-10 Queensland University Of Technology Growth factor complexes and modulation of cell migration and growth
CA2781474C (en) 2009-11-30 2019-06-18 Queensland University Of Technology Fibronectin: growth factor chimeras
US9862750B2 (en) 2012-06-11 2018-01-09 University Of Newcastle Upon Tyne Recombinant polypeptide
CN114557908B (en) * 2022-03-22 2023-11-17 芜湖英特菲尔生物制品产业研究院有限公司 Fibronectin composition freeze-dried micro-core with skin barrier repair effect and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192743A (en) * 1992-01-16 1993-03-09 Genentech, Inc. Reconstitutable lyophilized protein formulation
US5652225A (en) * 1994-10-04 1997-07-29 St. Elizabeth's Medical Center Of Boston, Inc. Methods and products for nucleic acid delivery
JPH10137334A (en) * 1996-11-07 1998-05-26 Toagosei Co Ltd Functional material

Also Published As

Publication number Publication date
WO2000055206A1 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
AU2583399A (en) Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
AU5023300A (en) Vascular endothelial growth factor variants
AU1941301A (en) Implantable nickel-free stainless steel stents
HUP0200827A3 (en) Vascular endothelial cell growth factor variants and uses thereof
AU3374795A (en) Conjugates of vascular endothelial growth factor with targeted agents
AU5439998A (en) Vascular endothelial growth factor
AU6379700A (en) Method of promoting bone growth with hyaluronic acid and growth factors
AUPQ402999A0 (en) Improvements in or relating to growth containers
AU2951599A (en) Synthesis of biologically active compounds in cells
AU2002363322A8 (en) Endothelial cell derived hemotopoietic growth factor
AU4492900A (en) Apple promoters for expression of transgenes in plants
AU3897200A (en) Endothelial cell stimulation by a complex of fibronectin and vascular endothelial growth factor
AU6874900A (en) Materials for culturing cardiovascular tissues and method of tissute regeneration
AU2786100A (en) Method of selecting transformed cells and tissues
AU2878200A (en) Growth medium for human corneal endothelial cells
AU5026100A (en) Vascular endothelial growth factor dimers
AU6162698A (en) Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof
AU6294700A (en) Anti-idiotypic antibodies of fibroblast growth factors and their use as medicines
GB9916790D0 (en) Storage of microorganisms,cells and tissue
AU3147799A (en) Para-poxvirus-coded vascular endothelial cell growth factor (ppv-vegf)
AU4774200A (en) Long term cell culture of human carcinoma
AU5903600A (en) A novel vascular endothelial growth factor family member and uses thereof
AU3693000A (en) Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof
AU2001277733A1 (en) Chimeric human-type vascular endothelial cell growth factor
AU3373300A (en) Method of modifying cytotoxic cells and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase